Li et al. found that ALKBH5 changes the content of lactate in the tumor microenvironment by altering mRNA splicing and the expression of the target gene Mct4/Slc16a3, thereby affecting the recruitment of regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs). The gene discussed is SLC16A3; the disease is neoplasm.